Viyash Scientific LtdNSE: VIYASH
Open the Viyash Scientific Ltd page
Follow Viyash Scientific LtdFree account. Get a note when Viyash Scientific Ltd files.
Q1 FY27 results analysis · August 11, 2026

Viyash Scientific Ltd Q1 FY27 Results Analysis: PAT Jumps 107%, Revenue Grows 19.5%

+115.2%PAT year on year, Rs. 79.29 Cr
Cofacto ResearchPublished August 11, 20262 min readPositive read
Quick summary

Viyash Scientific Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 946.36 Cr (+19.54% YoY) and PAT growth of +115.20% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 11, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 946.36 Cr (+19.54% YoY)
PAT (Q1)Rs. 79.29 Cr (+115.20% YoY)
EBITDA margin18.85% (+400 bps YoY)
EPS (Q1)Rs. 1.51 (+104.00% YoY)
Market capRs. 11,415.85 Cr
CMPRs. 261.45

Quarter Snapshot

Strong 19.5% YoY revenue growth and 107% PAT growth underscored by margin expansion, debt reduction, and successful Alivira subsidiary integration. QoQ EBITDA margin slipped due to cost upticks and a one-off ESOP charge, but ex-ESOP margin remains above 20%. Post-quarter BioForLife acquisition adds visibility to future growth.

Key Investment Insights

Key Positives

  • Revenue grew 19.5% YoY to Rs.946.36 Cr, second-highest quarterly revenue ever.
  • PAT attributable to owners grew 107% YoY to Rs.65.87 Cr.
  • EBITDA margin expanded 400 bps YoY to 18.85% (P&L-derived).
  • Finance costs declined 38.8% YoY to Rs.12.51 Cr, reflecting debt reduction.
  • Subsidiary contribution to PAT surged 209.8% YoY to Rs.44.95 Cr, highlighting Alivira merger benefits.
  • Net debt/EBITDA at 0.2x, very low leverage.
  • Ex-ESOP normalized PAT margin ~9.8%, indicating strong underlying profitability.

Risk Factors

  • QoQ EBITDA margin declined 118 bps from 20.03% to 18.85%, driven by higher material and employee costs.
  • Material cost ratio increased 102 bps QoQ to 45.89%.
  • Hyperinflation loss in Turkey of Rs.1.44 Cr vs a gain of Rs.3.71 Cr in Q1FY26, a recurring headwind.
  • ESOP incremental charge of ~Rs.19.30 Cr burdened employee costs and depressed reported margins.

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.